еНаука - преглед

Преглед према Аутор Reusch, Michael

Приказ резултата 1 до 15 од 15
ГодинаНасловАутор(и)Тип резултатаМп-кат.
2021Cardiovascular outcomes associated with achieved haemoglobin level and preliminary rate of rise of haemoglobin in pooled phase 3 studies of roxadustat in non-dialysis-dependent patients with anaemiaBarratt, Jonathan; Sulowicz, Wladyslaw; Cockburn, Elinor; Reusch, Michael; Young, James; Dimkovic, Nada BКонференцијски рад
Мп категорија ће бити приказана накнадно.
2021Cardiovascular Outcomes Associated with Achieved Haemoglobin Level in Pooled Phase 3 Studies of Roxadustat in Non-Dialysis-Dependent Patients with AnaemiaBarratt, Jonathan; Sulowicz, Wladyslaw; Cockburn, Elinor; Reusch, Michael; Young, James; Dimkovic, Nada BКонференцијски рад
Мп категорија ће бити приказана накнадно.
2022Cardiovascular Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients With Chronic Kidney Disease Incident to or Not Receiving Dialysis: Pooled Subgroup Analysis of Four Phase 3 StudiesEsposito, Ciro; Barratt, Jonathan; Dellanna, Frank; Portoles, Jose; Choukroun, Gabriel; De, Nicola Luca; Reusch, Michael; Young, James; Jiletcovici, Alina; Dimkovic, Nada BКонференцијски рад
Мп категорија ће бити приказана накнадно.
2022Iron Parameters in Patients Treated With Roxadustat for Anemia Associated With Chronic Kidney Disease: Post Hoc Analysis of the Non-Dialysis-Dependent or Incident Dialysis Population From Four Phase 3 StudiesEsposito, Ciro; Barratt, Jonathan; Dellanna, Frank; Portoles, Jose; Choukroun, Gabriel; De, Nicola Luca; Reusch, Michael; Young, James; Jiletcovici, Alina; Dimkovic, Nada BКонференцијски рад
Мп категорија ће бити приказана накнадно.
2021Pooled Efficacy and Cardiovascular Safety Results of 3 Placebo-Controlled and 1 Darbepoetin Alfa-Controlled Studies of Roxadustat for Treatment of Anaemia in Patients with Non-Dialysis-Dependent Chronic Kidney DiseaseBarratt, Jonathan; Dimkovic, Nada B; Shutov, Evgeny; Sulowicz, Wladyslaw; Esposito, Ciro; Reusch, Michael; Young, James; Mariat, ChristopheКонференцијски рад
Мп категорија ће бити приказана накнадно.
2021Pooled efficacy and cardiovascular safety results of roxadustat compared with placebo/ darbepoetin alfa for treatment of anaemia in patients with non-dialysis-dependent (NDD) chronic kidney disease (CKD)Barratt, Jonathan; Dimkovic, Nada B; Shutov, Evgeny; Sulowicz, Wladyslaw; Esposito, Ciro; Reusch, Michael; Young, James; Mariat, ChristopheКонференцијски рад
Мп категорија ће бити приказана накнадно.
2021Regional Efficacy and Safety Results of Roxadustat Compared with Placebo Or Darbepoetin Alfa in Non-Dialysis-Dependent (Ndd) Chronic Kidney Disease (Ckd) Patients with AnaemiaDimkovic, Nada B; Esposito, Ciro; Barratt, Jonathan; Mariat, Christophe; Shutov, Evgeny; Reusch, Michael; Young, James; Sulowicz, WladyslawКонференцијски рад
Мп категорија ће бити приказана накнадно.
2020Roxadustat for the Treatment of Anaemia in Chronic Kidney Disease Patients Not on Dialysis: a Phase 3, Randomised, Open-Label, Active-Controlled StudyBarratt, Jonathan; Andric, Branislav R; Tataradze, Avtandil; Schoemig, Michael; Reusch, Michael; Valluri, Udaya; Mariat, ChristopheКонференцијски рад
Мп категорија ће бити приказана накнадно.
2022Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomised, open-label, active-controlled study (DOLOMITES) (vol 36, pg 1616, 2021)Barratt, Jonathan; Andric, Branislav R; Tataradze, Avtandil; Schomig, Michael; Reusch, Michael; Valluri, Udaya; Mariat, ChristopheОстало
Мп категорија ће бити приказана накнадно.
2021Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)Barratt, Jonathan; Andric, Branislav R; Tataradze, Avtandil; Schoemig, Michael; Reusch, Michael; Valluri, Udaya; Mariat, ChristopheНаучни чланак
21M21 - Рад у врхунском међ. часопису
2020Roxadustat for the treatment of anemia in chronic kidney disease (CKD) patients not on dialysis (NDD): a phase 3, randomized, open-label, active-controlled studyBarratt, Jonathan; Andric, Branislav R; Tataradze, Avtandil; Schoemig, Michael; Reusch, Michael; Valluri, UdayaКонференцијски рад
Мп категорија ће бити приказана накнадно.
2021Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS)Shutov, Evgeny; Sulowicz, Wladyslaw; Esposito, Ciro; Tataradze, Avtandil; Andric, Branislav R; Reusch, Michael; Valluri, Udaya; Dimkovic, Nada BНаучни чланак
21M21 - Рад у врхунском међ. часопису
2020Roxadustat for the Treatment of non-dialysis-dependent Patients with Anaemia in chronic Renal Insufficiency: A Phase III, randomised, "open-label", active-controlled TrialBarratt, Jonathan; Andric, Branislav R; Tataradze, Avtandil; Schoemig, Michael; Reusch, Michael; Valluri, Udaya; Mariat, Christophe; Sunder-Plassmann, GereКонференцијски рад
Мп категорија ће бити приказана накнадно.
2022Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients with Chronic Kidney Disease Incident to Or Not Receiving Dialysis: Pooled Analysis of Four Phase 3 StudiesBarratt, Jonathan; Dellanna, Frank; Portoles, Jose; Choukroun, Gabriel; De, Nicola Luca; Reusch, Michael; Young, James; Dimkovic, Nada BКонференцијски рад
Мп категорија ће бити приказана накнадно.
2023Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 StudiesBarratt, Jonathan; Dellanna, Frank; Portoles, Jose; Choukroun, Gabriel; De, Nicola Luca; Young, James; Dimkovic, Nada B; Reusch, MichaelНаучни чланак
22M22 - Рад у истакнутом међ. часопису